InnoCan Pharma Corporation (INNO.CN)
Canadian Sec · CAD · Consumer Defensive · Household & Personal Products
CA$1.90 (+0.00%) as of
Key statistics
- Market cap
- 8.55M
- EPS (TTM)
- -0.3600
- Dividend yield
- 0.00%
- 52-week range
- 1.6000 – 19.1500
- Beta
- 0.30
- Revenue (TTM)
- 23.52M
- Profit margin
- -4.08%
- Volume
- 100.00
About InnoCan Pharma Corporation
InnoCan Pharma Corporation operates as a pharmaceutical technology company in United States, Canada, Europe, and internationally. The company operates through two segments, Online sales and Other Operations. The company develops a cannabidiol (CBD)-loaded liposome drug delivery platform (CBD-LPT), which is in the preclinical trial phase to treat chronic pain management for human and veterinary health sectors. It also offers a pain-relieving topical composition, as well as compositions for the treatment of hemorrhoid, psoriasis of the scalp, vaginal atrophy, and diabetic symptoms. The company is also involved in development, manufacture, and marketing of cosmetic products. InnoCan Pharma Corporation was founded in 2017 and is headquartered in Calgary, Canada.
- Sector
- Consumer Defensive
- Industry
- Household & Personal Products
- Headquarters
- Calgary, AB, Canada
Financial statements (income statement, balance sheet, cash flow) and an interactive price chart are available on this page with JavaScript enabled.